Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy

被引:54
作者
Tarnow, L
Rossing, P
Jensen, C
Hansen, BV
Parving, HH
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] UNI C, Aarhus, Denmark
关键词
D O I
10.2337/diacare.23.12.1725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare the long-term effect on kidney function of a long-acting calcium antagonist (nisoldipine) versus a long-acting ACE inhibitor (lisinopril) in hypertensive type 1 diabetic patients with diabetic nephropathy. RESEARCH DESIGN AND METHODS - We performed a 4-year prospective, randomized, double-dummy controlled study comparing nisoldipine (20-40 mg once a day) with lisinopril (10-20 mg once a day). The study was double-blinded for the first year and single-blinded thereafter. The study included 51 hypertensive type 1 diabetic patients with diabetic nephropathy. Three patients dropped out during the first month; results for the remaining 48 patients are presented. RESULTS - At baseline, the two groups were comparable: glomerular filtration rate (GFR) was 85 +/- 5 and 85 +/- 6 mi min(-1) [1.73 m](-2); mean 24-h ambulatory blood pressure was 108 +/- 3 and 105 +/- 2 mmHg, and albuminuria was 1,554 mg/24 h (95% CI 980-2,465) and 1,033 mg/24 h (760-1,406) in the lisinopril and nisoldipine groups, respectively. Mean 24-h arterial blood pressure during the study did not differ between the lisinopril and nisoldipine groups (100 +/- 2 and 103 +/- 1 mmHg, respectively). The time-course of albuminuria differed between groups (P < 0.001). Whereas initiation of treatment with lisinopril resulted in a reduction from baseline albuminuria by 52% (95% CI 14-73), albuminuria in the nisoldipine group did not change throughout the study. GFR declined in a biphasic manner with an initial (0-6 months) reduction of 1.3 +/- 0.3 ml.min(-1).month(-1) in the lisinopril group compared with 0.2 +/- 0.4 ml.min(-1).month(-1) in the nisoldipine group (P < 0.01). The subsequent sustained decline (6 to 48 months or the end of treatment) was identical in the two groups: 0.5 +/- 0.1 ml.min(-1).month(-1) (NS). Two patients in the lisinopril group and three patients in the nisoldipine group entered therapy for end-stage renal failure. CONCLUSIONS - Long-term treatment with lisinopril or nisoldipine has similar beneficial effects on progression of diabetic nephropathy in hypertensive type 1 diabetic patients.
引用
收藏
页码:1725 / 1730
页数:6
相关论文
共 30 条
[1]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[2]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[3]   RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY [J].
BJORCK, S ;
MULEC, H ;
JOHNSEN, SA ;
NORDEN, G ;
AURELL, M .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823) :339-343
[5]   SELECTION OF ROUTINE METHOD FOR DETERMINATION OF GLOMERULAR-FILTRATION RATE IN ADULT PATIENTS [J].
BROCHNERMORTENSEN, J ;
RODBRO, P .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1976, 36 (01) :35-43
[6]  
Estacio RO, 2000, DIABETES CARE, V23, pB54
[7]   ENZYME-IMMUNOASSAY - AN IMPROVED DETERMINATION OF URINARY ALBUMIN IN DIABETICS WITH INCIPIENT NEPHROPATHY [J].
FELDTRASMUSSEN, B ;
DINESEN, B ;
DECKERT, M .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (06) :539-544
[8]   CONTRASTING EFFECTS OF LISINOPRIL AND NIFEDIPINE ON ALBUMINURIA AND TUBULAR TRANSPORT FUNCTIONS IN INSULIN-DEPENDENT DIABETICS WITH NEPHROPATHY [J].
HOLDAAS, H ;
HARTMANN, A ;
LIEN, MG ;
NILSEN, L ;
JERVELL, J ;
FAUCHALD, P ;
ENDRESEN, L ;
DJOSELAND, O ;
BERG, KJ .
JOURNAL OF INTERNAL MEDICINE, 1991, 229 (02) :163-170
[9]  
Hovind P., 1998, Journal of the American Society of Nephrology, V9, p116A
[10]  
JENSEN T, 1989, DIABETES RES CLIN EX, V10, P93